Articles On Anteo Diagnostics (ASX:ADO)

In late trade, the S&P/ASX 200 Index (ASX: XJO) is on course to end the week with on a positive note. At the time of writing, the benchmark index is up 2.2% to 6,990.9 points. Four ASX shares that have failed to follow the market highe...

Key Points AnteoTech shares sink on additional request for information by the TGA The company submitted a performance report last week to the TGA Study timeline date impacted by Omicron outbreak and staff shortage across healthcare system...

Stockhead’s Top 10 at 10, published at 10.30am each trading day, highlights the best (and worst) performing ASX small caps in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest mov...

AnteoTech (ADO) receives a call for further information from the Therapeutic Goods Administration The new request relates to the collation of further clinical data on the company’s EuGeni Reader and SARS CoV- 2 Ag Rapid Diagnostic Test (RD...

Each week, Stockhead recaps ASX stocks that are “running hot” as deduced by the Relative Strength Index (RSI). The RSI is a technical gauge which measures how trading momentum is affecting the price action. A reading of 70 is seen as the le...

In afternoon trade, the S&P/ASX 200 Index (ASX: XJO) is on course to end the week deep in the red. At the time of writing, the benchmark index is down 2.1% to 7,182.8 points. Four ASX shares that have managed to avoid the selloff and p...

Key points The AnteoTech share price soared again today, taking its gains over the past week to 42% Demand for rapid antigen tests is increasing The company’s CEO is hitting media headlines this week The AnteoTech Ltd (ASX: ADO) shar...

In afternoon trade, the S&P/ASX 200 Index (ASX: XJO) is on course to end the week with a decline. At the time of writing, the benchmark index is down 1% to 7,399.7 points. Four ASX shares that are not letting that hold them back are li...

Key points Ellume is in the spotlight as the United States Government looks to buy another 500 million RATs Additionally, the company has reportedly started working to get approval to sell its tests in Australia There’s still no word of E...

Key points The Lumos Diagnostics share price is rising today COVID-19 rapid antigen tests are in focus this week The company’s CoviDX RAT test is waiting on TGA approval The Lumos Diagnostics Holdings Ltd (ASX: LDX) share price is risi...

Key points The AnteoTech share price is up 4% in early morning trade. The gain may relate to reports AnteoTech’s boss is hopeful its RAT device is in the final stages of TGA approval The company’s reportedly preparing to ramp up productio...

The S&P/ASX 200 Index (ASX: XJO) looks set to record its first decline of the year today. In afternoon trade, the benchmark index is down 0.3% to 7,565.7 points. Four ASX shares that are not letting that hold them back are listed below...

The AnteoTech Ltd (ASX: ADO) share price has soared since the start of the pandemic as the company has worked to create a COVID-19 rapid antigen test. Enthusiasm surrounding the now-developed point-of-care rapid testing device has helped...

In late morning trade, the S&P/ASX 200 Index (ASX: XJO) is fighting hard to record another gain. At the time of writing, the benchmark index is up slightly to 7,514.4 points. Four ASX shares that are climbing more than most today are l...

It’s been a rocky two weeks for small-cap health companies with 42 gaining ground, 76 losing it, and 21 flatlining.   Here’s a table showing how ASX-listed healthcare stocks have been performing. CODE COMPANY PRICE 1 WEEK RETURN %...

Shares in Anteotech Ltd (ASX: ADO) are spiking well into the green during afternoon trade and now change hands 12.5% higher at 22.5 cents apiece. Whilst there’s been no market-sensitive information from the company’s end today, Anteotech...

Medical diagnosis technology company AnteoTech (ASX: ADO) has made the Brisbane Top Companies list for the first time as investor interest was buoyed by its relationship as a supplier to Ellume, another med-tech founded by former Brisbane Y...

It’s been a mad Monday on the ASX as the broader index struggled to mitigate a general sell-off, but the AnteoTech Ltd (ASX: ADO) share price has weathered the storm. At the market close, the company’s stock is trading flat with its previo...

The Anteotech Ltd (ASX: ADO) share price is falling in early trading this morning. This comes after the research and development company released its quarterly activities and earnings update. Shares in Anteotech are now changing hands at...

AM Diagnostics has been on the radar of many ASX-watchers recently. Particularly, after at-home COVID-19 antigen rapid tests, supplied by the Perth-based Australian company, received approval from the Therapeutic Goods Association (TGA) t...

Local markets looked brighter today. US share markets rebounded on Friday. Global oil prices also rose by around 1% on ahead of a meeting of OPEC+ producers today. Analysts expect that producers will add just 400,000 barrels per day in extr...

The Anteotech Ltd (ASX: ADO) share price has been soaring over the last 30 days on the back of numerous announcements. Over last month, the company has signed 3 distribution agreements and submitted its SARS-CoV-2 Antigen Rapid Diagnostic...

The AnteoTech Ltd (ASX: ADO) share price is rocketing today. This comes after news the company has submitted its SARS-CoV-2 antigen rapid diagnostic test for Therapeutic Goods Administration (TGA) approval. According to the company, its ra...

The ASX 200 has tracked lower in Friday trade, rounding out a choppy week where local stocks struggled for direction. The index was dragged lower by another brutal session for the big miners as iron ore prices tanked again, led by a 15% dro...

In afternoon trade, the S&P/ASX 200 Index (ASX: XJO) is on course to end the week deep in the red. At the time of writing, the benchmark index is down 0.8% to 7,400.6 points. Four ASX shares that are not letting that hold them back tod...

In afternoon trade, the S&P/ASX 200 index (ASX: XJO) is on course to finish in the green and is up 0.5% to 7,455.9 points. At the same time, the S&P/ASX 200 Health Care index (XHJ) is also up 0.7% from the open. Yet, these 3 ASX...

The AnteoTech Ltd (ASX: ADO) share price is accelerating to a 2-month high today. This comes after the surface chemistry company announced a distribution agreement for its EuGeni Rapid Diagnostic Platform. At the time of writing, AnteoTech...

In afternoon trade, the S&P/ASX 200 Index (ASX: XJO) has followed Wall Street’s lead and is storming higher. At the time of writing, the benchmark index is up 0.6% to 7,460 points. Four ASX shares that are climbing more than most today...

Anteotech (ASX:ADO) is another fine example of a chart pattern that we appreciate at Collette Capital. Namely a company that has demonstrated the capacity to put significant runs on the board when capturing the interest of the market, that...

In afternoon trade, the S&P/ASX 200 Index (ASX: XJO) is on course to record a decline. At the time of writing, the benchmark index is down 0.4% to 7,500.6 points. Four ASX shares that are not letting that hold them back are listed belo...

In afternoon trade, the S&P/ASX 200 Index (ASX: XJO) is on course to start the week with a disappointing decline. At the time of writing, the benchmark index is down 0.5% to 7,484.6 points. Four ASX shares that are not letting that hol...

Summary A panic selling in oil and gold prices and concerns over the rapid spread of the Delta variant of coronavirus dented global sentiment. The market breadth is very positive with 10 out of the 11 sectors trading higher today. Cha...

ADO share price is up as much as 18.9% in early trade, peaking at 22 cents. The AnteoTech (ASX:ADO) has signed a distribution agreement for its EuGeni reader and SARS-CoV-2 rapid diagnostic test in the Philippines.  The post AnteoTech Sign...

Local stocks tracked higher on Friday in a relatively calm session to end the week. The ASX200 traded flat, edging higher by 0.36% into the close. Those gains were comfortably outpaced by the small end of town, as the microcap Emerging Comp...

In late morning trade, the S&P/ASX 200 Index (ASX: XJO) is fighting hard to finish the week on a positive note. At the time of writing, the benchmark index is up almost 0.1% to 7,516.5 points. Four ASX shares that are climbing more tha...

The AnteoTech Ltd (ASX: ADO) share price is breaking its negative streak this week to surge higher today. This comes after the nanotechnology company announced that it has partnered with in-vitro diagnostic products supplier, UC Bioscienc...

Summary The ASX 200 ended 52.10 points or 0.70% lower at 7,379.30 on Wednesday. The market sentiments were dented by spike in inflation and extension of curbs in Greater Sydney. Investors turned caution ahead of US Fed meeting outcome...

Materials science company, AnteoTech (ASX:ADO), shares are on the up today. The stock is currently trading 8.89% higher, thanks to some good news regarding an ongoing product rollout. The post AnteoTech Shares Spike 8.9% Higher as It Unveil...

Materials science company, AnteoTech (ASX:ADO), the ADO share price is up today. The stock is currently trading 8.89% higher, thanks to some good news regarding an ongoing product rollout. The post AnteoTech Share Price Up as It Unveils UK...

Unlisted company Ellume is making headlines again with reports claiming Australian governments are being lobbied to approve the use of at-home rapid COVID-19 tests. While it would be the dream of many investors to see Ellume debut on the A...

Summary Openpay (ASX:OPY) delivers strong growth in Q4 FY21, marks 141% rise in active plans Rio Tinto (ASX:RIO) commits to fund Jadar lithium project Cashrewards’ (ASX:CRW) future Max™ launch begets strong growth in June quarter...

Summary The ASX 200 traded lower by 24 points or 0.32% at 7,408 by the lunch. Six of 11 sectors were in red, while tech and energy dropped the most. Investment fund Spark Infrastructure Group was the top performer with 5% gain. ...

ASX 200 health stocks index rose by 0.21% this morning, compared to the broader index which fell by 0.22%. Chimeric Therapeutics (ASX:CHM) rose by 6% after obtaining the exclusive license to a novel CAR-T for solid tumours from the Universi...

The AnteoTech Ltd (ASX: ADO) share price is bouncing around today with above-average trading volume. This comes as Ellume secures further approvals from the United States Food and Drug Administration (FDA) for its COVID-19 rapid antigen ho...

Healthcare is a constantly changing industry in which you may be asking yourself if your investments are up to date. While the healthcare sector underperformed the S&P/ASX 200 Index (ASX: XJO) in FY21, there were still some ASX-listed...

Shares in ASX biotech companies Anteotech Ltd (ASX: ADO), Imugene Ltd (ASX: IMU) and Little Green Pharma Ltd (ASX: LGP) have all posted exciting gains over the past 12 months. Let’s have a look at the share price performance and recent ne...

It’s been a wild day of trading for AnteoTech Ltd [ASX:ADO]. After opening higher, shares in the company began to fall just an hour after trading. The post AnteoTech Share Price Down 5% after Opening Higher, Here’s Why appeared first on Mon...

It’s been a wild day of trading for AnteoTech [ASX:ADO]. After opening higher, shares began to fall just an hour after trading. With the share price currently sitting at 32 cents, down 5.8%... The post AnteoTech Shares Down after Opening Hi...

The S&P/ASX 200 Index (ASX: XJO) is on course to record a small gain. At the time of writing, the benchmark index is up almost 0.2% to 7,042.4 points. Four ASX shares that have failed to follow the market higher today are listed below....

Summary AnteoTech offers EuGeni SARS-CoV-2 antigen rapid diagnostic test kit. The Company plans to commence in-house manufacturing in Brisbane, expected to bring the total annual production to 32 million test strips. Discussions with...